Liver cancer breakthrough? new study tests Post-Surgery treatment to stop return
NCT ID NCT07417397
First seen Feb 21, 2026 · Last updated Jun 15, 2026 · Updated 17 times
Summary
This study tests whether a procedure called TACE, given after liver cancer surgery, can help prevent the cancer from returning in patients at high risk of recurrence. About 442 adults who had their liver cancer completely removed will be randomly assigned to receive either TACE or regular follow-up scans. The goal is to see if TACE improves how long people stay cancer-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Guangxi Medical University Cancer Hospital
RECRUITINGNanning, 530021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.